JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/22718

Title: Targeted alpha therapy with 213Bi
Authors: MORGENSTERN Alfred
Citation: Current Radiopharmaceuticals vol. 4 no. 4 p. 295 - 305
Publisher: Bentham Science Publishers Ltd.
Publication Year: 2011
JRC Publication N°: JRC64087
ISSN: 1874-4710
URI: http://www.benthamdirect.org/pages/content.php?CRP/2011/00000004/00000004/0003CRP.SGM
DOI: 10.2174/1874471011104040295
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.


The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace